BSBagdan S. Semchenko

Bagdan S. Semchenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bagdan S. Semchenko has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Sergey K. Efetov

    I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

    3 shared publications
  • Arina K. Rychkova

    Department of Faculty Surgery No. 2, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

    2 shared publications
  • Albina A. Zubayraeva

    Department of Faculty Surgery 2 of N.V. Sklifosovsky Clinical Medicine Institute I.M. Sechenov First Moscow State Medical University (Sechenov University) Moscow Russia

    1 shared publication
  • Denis I. Khlusov

    I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

    1 shared publication
  • Jin Zhang

    Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, 39216, USA

    1 shared publication
  • Jinqi Zou

    National Medical Innovation Platform for Industry-Education, Integration in Advanced Medical Devices, (Interdiscipline of Medicine and Engineering); Key Laboratory of Innovation and Transformation of Advanced Medical Devices, Ministry of Industry and Information Technology; Institute of Medical Photonics, Beijing Advanced Innovation Center for Biomedical Engineering; School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, P. R. China

    1 shared publication

Latest Publications

  • Evaluation of the efficacy of natural orifice specimen extraction surgery versus conventional laparoscopic surgery for colorectal cancers: A systematic review and meta‐analysis

    by Yu Cao, Mingze He, Zheng Liu, Kuo Chen, Khlusov Denis, Jin Zhang, Jinqi Zou, Bagdan S. Semchenko, Sergey K. Efetov

    Aim: Natural orifice specimen extraction surgery (NOSES) has gained significant importance in treating cancers. The current study is a meta‐analysis that aimed to assess the short‐term efficacy and long‐term prognostic impact of NOSES and conventional laparoscopic (CL) surgery in the treatment of colorectal cancer (CRC).Method: Published reports in several medical databases up to February 2024 were searched and information pertinent to outcomes of NOSES and CL in retrospective and randomized studies to treat CRC was collected. Pooled weighted/standardized mean difference (WMD/SMD), odds ratio (OR) and hazard ratio (HR) with 95% confidence interval (CI) were calculated using a fixed‐effects model or random‐effects model, and meta‐analysis was subsequently performed using Stata.Results: Thirty‐one studies with a total of 4637 patients were included in this meta‐analysis. When compared with CL, NOSES had significant advantages in several indicators, such as wound infection [OR = 0.22 (95% CI 0.13–0.38); Z = 5.56, p = 0], incisional hernia [OR = 0.24 (95% CI 0.11–0.54); Z = 3.44, p = 0.001], blood loss [WMD = −10.17 (95% CI −14.75 to −5.60); Z = 4.36, p = 0], incision length [WMD = −4.94 (95% CI −5.27 to −4.60); Z = 29.10, p = 0.00], postoperative pain [WMD = −1.43 (95% CI −1.69 to −1.18); Z = 11.02, p = 0.00], use of additional analgesics [OR = 0.57 (95% CI 0.39–0.82); Z = 3.06, p = 0.002], hospital stay [WMD = –1.25 (95% CI −1.58 to –0.93); Z = 7.65, p = 0.00], gastrointestinal recovery [WMD = −13.42 (95% CI −17.77 to −9.07); Z = 6.05, p = 0.00], first flatus [WMD = −0.50 (95% CI −0.68 to −0.32); Z = 5.34, p = 0.00] and cosmetic result [WMD = 2.11 (95% CI 0.92–3.30); Z = 3.47, p = 0.001]. However, NOSES required a significantly longer duration of surgery [WMD = 14.13 (95% CI 6.70–21.56); Z = 3.73, p = 0.00]. There were no significant differences in postoperative anastomotic leakage, intra‐abdominal infection, lymph node harvest, proximal and distal margins, 5‐year disease‐free and 5‐year overall survival and pelvic floor function.Conclusion: NOSES is considered an efficient surgical method of treatment for CRC that allows patients to have long‐term favourable oncological outcomes while recovering faster with minimal pain. However, these findings still require confirmation through studies on large population cohorts.


  • Open Access

    Primary Retroperitoneal Approach to the Superior Mesenteric Vessels in Minimally Invasive Surgical Treatment of Right Colon Cancer with D3 Lymph Node Dissection. Technique and First Short-Term Outcomes

    by S. K. Efetov, B. S. Semchenko, A. K. Rychkova

    Aim: to develop and describe the technique of primary retroperitoneal approach to the superior mesenteric vessels for D3 lymph node dissection in minimally invasive surgical treatment of the right colon cancer; to evaluate the shortterm results of the first series of patients operated by this technique.Materials and methods. Patients with adenocarcinoma of the right colon were included in the study. The technique of primary retroperitoneal approach consisted in mobilization of the right mesocolon along the posterior surface in the direction of the superior mesenteric vessels, D3 lymph node dissection with crossing of the feeding vessels from the retroperitoneal side using a single-port access system and consisted of five consecutive steps. At the last step of the procedure the peritoneum and the remaining part of the mesentery were crossed laparoscopically to the intended borders of the colon resection. The specimen was extracted through the incision for the single port, followed by the formation of an anastomosis extracorporeally. The endpoints of the study were the short-term results of surgical treatment.Results. The study presents data of the first 5 patients with adenocarcinoma of the right colon who underwent surgical treatment with D3 lymph node dissection using primary retroperitoneal approach to the superior mesenteric vessels. The duration of the retroperitoneal step averaged 110 (90–140) min. The average blood loss was 62 (10–100) mL. The first two patients underwent a three-stage retroperitoneal portion of the surgery. The other three patients were successfully operated by primary retroperitoneal approach with performing of all five steps of the operation. The number of removed regional lymph nodes was on average 36 (18–57), apical lymph nodes — 6 (4–5), metastatic regional lymph nodes — 3 (2–4). One patient developed a Class 1 Clavien — Dindo complication, which did not require a change in treatment tactics. The average postoperative hospital stay was 8 (5–12) days.Conclusion. The technique of primary retroperitoneal approach to the superior mesenteric vessels to perform D3 lymph node dissection was described for the first time. The obtained results demonstrated the possibility of using this method for minimally invasive radical treatment of right colon cancer.

  • Primary retroperitoneal approach for vessel-sparing D3-lymph node dissection in left colonic and rectal cancer resections — the first Russian experience

    by S.K. Efetov, A.A. Zubayraeva, B.S. Semchenko, P.D. Panova, M.V. Volgin, A.K. Rychkova

    ЦЕЛЬ ИССЛЕДОВАНИЯ Разработать и описать технику первично-забрюшинного доступа для выполнения сосудосберегающей расширенной лимфодиссекции при операциях по поводу рака левой половины ободочной и прямой кишки. Оценить непосредственные результаты первой серии пациентов, оперированных по новой малоинвазивной методике. МАТЕРИАЛ И МЕТОДЫ В исследование вошли первые 10 пациентов с аденокарциномой левых отделов ободочной и прямой кишки, которым выполнено резекционное вмешательство забрюшинным доступом с сосудо-сохраняющей Д3-лимфодиссекцией. Техника первично-забрюшинного доступа заключалась в выполнении мобилизации левых отделов ободочной кишки, Д3-лимфодиссекции со скелетизацией нижней брыжеечной артерии (НБА), селективного пересечения питающих сосудов со стороны забрюшинного пространства с помощью системы единого доступа SILS на первых этапах операции. Пересечение висцеральной и париетальной брюшины, а также пересечение брыжейки до уровня границ резекции кишки выполнялось лапароскопическим способом. Операционный препарат извлекался через разрез для забрюшинного доступа. Конечными точками исследования стали непосредственные результаты хирургического лечения. РЕЗУЛЬТАТЫ Длительность забрюшинного этапа составила 90 мин (65—110) при лимфодиссекции забрюшинным доступом. Число удаленных регионарных лимфоузлов при сосудосберегающей Д3-лимфодиссекции со скелетизацией НБА составило в среднем 28,5 (22—37), метастатических регионарных — 3 (1—4), а апикальных — 3,5 (2—5). У 4 из 10 пациентов при забрюшинной диссекции была повреждена висцеральная брюшина на этапе освоения методики. У двух пациентов развились осложнения 1—2 класса по классификации Clavien—Dindo. Средний послеоперационный койко-день составил 8 суток (5—12). ЗАКЛЮЧЕНИЕ В рамках данного исследования разработана и внедрена забрюшинная Д3-лимфодиссекция по сосудосохраняющей методике при лечении рака левых отделов ободочной и прямой кишки. Первые результаты продемонстрировали безопасность и выполнимость нового метода.